Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
for Recurrent Glioma
27 locations incl. Aurora
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05859334·Phase 2·Recruiting